Recent discussions have centered on whether Ivermectin, a drug primarily used to treat parasitic infections, could hold potential as a cancer treatment. The inquiry stems from laboratory studies suggesting Ivermectin may have anti-cancer properties, prompting investigation into its mechanisms. However, oncologists are urging caution, emphasizing that these are preliminary findings and far from clinical application. Experts stress the urgent need for rigorous, peer-reviewed clinical trials to determine Ivermectin’s efficacy and safety for cancer treatment. Currently, Ivermectin is not a standard or approved cancer therapy anywhere. Oncologists caution against self-medication with Ivermectin for cancer, as it could interfere with established treatments and pose significant health risks. Further research is underway to explore the drug's potential, but definitive conclusions remain distant.